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Summary
Objective: To evaluate the clinical usefulness of the Diaquick Strep. A Test (SAT) as a rapid
streptococcal antigen test, and its effect on antibiotic use in children.
Methods: This was a prospective study of children with acute catarrh, fever, and acutely inflamed
throat/tonsils. Paired throat swabs for SAT and culture were collected. None of the children
received antibiotics prior to testing.
Results: Five hundred and five children were included in the study: 278 were boys (55%) and 409
(81%) were aged under 5 years. The SATwas negative in 434 cases (86%) and positive in 71 (14%);
culture was negative in 425 cases (84%) and positive in 80 (16%), including nine cultures that grew
bacteria other than group A b-hemolytic streptococci (GAS). Both the SAT and culture were
negative in 422 cases (84%) and positive in 68 (13%), but were inconsistent in 15 cases (3%). For
GAS infection, the SAT positive predictive value was 95.8% (68/71). The negative predictive value
for the whole group as well as for children under five years of age was over 99% (422/425 and 355/
358, respectively). SAT sensitivity was almost 96%. Finally, only 74 children (15%) were given
antibiotics, while a staggering 431 (85%) were not.
Conclusion: The Diaquick Strep. A Test (SAT) is a quick, reliable, and clinically useful test, which
could help to dramatically reduce the usage of antibiotics in childrenwith fever, catarrh, and acute
pharyngotonsillitis.
# 2007 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.* Corresponding author. Tel.: +971 504620493; fax: +971 65616699.
E-mail address: fadil2572@hotmail.com (F.Y.A. Al-Najjar).
201-9712/$32.00 # 2007 International Society for Infectious Diseases.
oi:10.1016/j.ijid.2007.07.006Introduction
Antibiotics have undoubtedly been highly effective in fighting
bacterial infections.1 However, their value has been seriously
threatened by the rapid emergence of multidrug-resistantPublished by Elsevier Ltd. All rights reserved.
A new rapid test for group A Streptococcus 309bacteria,2,3 and this has been compounded by the lack of any
new antibiotic structure since 1961.1
The threat to the use of antibiotics has been thoroughly
examined by the authorities on both sides of the Atlantic.4,5
Inappropriate use of antibiotics (about 50% in the developed
word) has been cited as amajor cause of bacterial resistance.5
Correlation between the use of antibiotics and bacterial resis-
tance has been documented in both inpatient6 and outpatient7
settings, and more importantly, measures to reduce their use
have led to a reduction in bacterial resistance rates.8,9
In children, upper respiratory tract infections (URTIs) are
very common, and although the majority are viral in origin,
antibiotics are frequently prescribed. Consequently, antibio-
tic use rates are highest for children, and approximately 75%
of outpatient antibiotics have been provided for some form of
URTI.10 Bacterial causes account for the minority of cases,
where group A b-hemolytic streptococci (GAS) are the most
common,11—13 affecting mainly school-aged children.
Although children infected with GAS will recover without
antibiotics, treatment is often recommended in order to
prevent complications such as acute rheumatic fever, nephri-
tis, and suppurative complications, and to hasten recovery
and prevent transmission to close contacts.14
Research confirms that antibiotics are not needed in the
majority of children with URTIs, including those under two
years of age with acute otitis media.15—17 At the national
level, campaigns based on educating doctors and the public
and applying evidence-based guidelines have been very
effective in reducing antibiotic use. In the Netherlands,
which adopted a ‘no initial antibiotics’ policy18 and the
UK, where a ‘delayed prescribing’ policy has been practiced,
a dramatic reduction in antibiotic use has been achieved.19
At the personal practice level, because viral and bacterial
URTIs are clinically indistinguishable20,21 and throat swab
culture results take 48 hours, efforts have been concentrated
on developing quick tests to detect GAS infections. The ideal
test should be quick, simple, and accurate. Furthermore,
adequate sensitivity is critical to ensure that such a test is
cost-effective in the management of children with GAS
infection.22,23 Previously tried rapid streptococcal antigen
tests have suffered the major limitation of low sensitivity
(ranging from 65.6% to 87.6%) requiring a back-up culture for
those with a negative test result.24—27
At Al-Zahra, we use a different rapid test — the Diaquick
Strep. ATest (SAT). It is a one-step thin-layer chromatography
sandwich type immunoassay for rapid, qualitative detection
of GAS antigen directly from throat swabs. According to the
manufacturer (Dialab GmbH, Vienna, Austria), this SAT is
90.5% sensitive and 97.5% specific, and results are obtained
within 5 minutes at room temperature. This prospective
study was designed to evaluate and validate the use of this
test in clinical practice, and to determine its effect on the
use of antibiotics.Patients and methods
This was a prospective study of children attending the out-
patient clinics of one pediatrician (FA) at the Al-Zahra Hospital
(AZH) and the Al-Zahra Medical Centre (AZMC). Children who
were seen at these clinics and fulfilled the inclusion criteria of
fever, acute catarrh, and acutely inflamed throat/tonsils withorwithout exudates, were included in the study. Childrenwith
clear viral infections like herpangina, herpetic stomatitis, and
adenoviral rhinoconjunctivitis were excluded, as well as those
who had received antibiotics during the preceding week.
Paired throat swabs for SAT and culture were collected. No
antibioticswere given before resultswere known. In all cases a
verbal consentwas obtained fromparents before enrolment in
the study, and they were subsequently kept informed about
the lab results.
Results
Five hundred and five children (408 from AZH and 97 from
AZMC) were included in the study over a two-year period
(2004—2006). Two hundred and seventy-eight (55%) were
boys and 227 (45%) were girls, while 409 (81%) were under
five years of age and 96 (19%) were over five (Table 1).
Overall, the SAT was negative in 434 cases (86%) and
positive in 71 (14%), whereas culture was negative in 425
cases (84%) and positive in 80 (16%), including nine cultures
that grew bacteria other than GAS.
Both the SATand culture were negative in 422 cases (84%)
and positive in 68 cases (13%), and in 15 cases (3%) results
were inconsistent (Table 2). In 12 cases where the SAT was
negative, three cultures grew GAS (later received antibio-
tics), seven grew Staphylococcus aureus, one grew Strepto-
coccus pneumoniae, and one grew coliform bacteria, but
none received antibiotics. In the remaining three children
the SAT was positive, and so antibiotics were given, but
cultures grew no GAS. Overall, 71 children (14%) had GAS
infection, defined as a positive throat culture.
In children with GAS pharyngotonsillitis, the positive pre-
dictive value of the SAT (the chance of a positive culture if
the SAT is positive) was very high at 95.8% (68/71). The
negative predictive value (the chance of a negative culture
if the SAT is negative) for the whole group as well as for
children under five years of age, was extremely high at over
99% (422/425 and 355/358, respectively). Furthermore, the
SAT sensitivity was very high at 95.8%.
Finally, out of a potential 505 antibiotic prescriptions,
only 74 children (15%) were given antibiotics, while a stag-
gering 431 (85%) were not (Table 3). Antibiotics were pro-
vided to all 71 children with a positive SAT (96% of the
antibiotic group) and to three children with a positive culture
for GAS. The usual antimicrobial regimen used is one of the
penicillins (amoxicillin, amoxicillin—clavulanate) or a sec-
ond-generation cephalosporin (cefprozil, cefuroxime) or a
macrolide (clarithromycin, azithromycin).
Discussion
The prevalence of multidrug-resistant bacteria has been
increasing at an alarming rate,2,3 and has been identified
as an increasing problem in pediatric practice17 as well as
being a major threat to public health.2,3 They are seriously
undermining the value of antibiotics in clinical medicine.3
Furthermore, bacterial resistance rates correlate well with
the volume of antibiotic consumption in communities.8,9,17
Inappropriate use of antibiotics has been identified as a very
important, potentially preventable factor in the develop-
ment of multidrug-resistant bacteria.
310 F.Y.A. Al-Najjar, S.A. Uduman
Table 3 Use of Antibiotics
Antibiotics Given (%) No Antibiotics (%)
74 (14.6%) 431 (85.4%)
Finally, out of a potential 505 antibiotic prescriptions, only 74
children (14.6%) were given antibiotics while, staggering, 431
(85.4%) were not.
Table 1 Patients Characteristics
Clinic Gender Age
AZH* (%) AZMC** (%) Boys (%) Girls (%) <5 yrs. (%) >5 yrs. (%)
408 (80.8%) 97 (19.2%) 278 (55%) 227 (45%) 409 (81%) 96 (19%)
505 children (408 fromAl-Zahra Hospital clinic & 97 fromAl-Zahra Medical Centre clinic) were included: 278 (55%) were boys & 227 (45%) girls
while 409 (81%) were <5 years & 96 (19%) were >5 years old.
* Al-Zahra Hospital.
** Al-Zahra Medical Centre
Table 2 Strep. A Test (SAT) and Throat Culture Results
SAT & Culture Results
Both Negative (%) Both Positive (%) Inconsistent (%)
422 (83.5%) 68 (13.5%) 15 (3%)
Both Strep A Test (SAT) & Culture were negative in 422 cases
(83.5%), positive in 68 (13.5%) and in 15 cases (3%) results were
inconsistent.In pediatric practice,URTIs are themost commonreason for
a child to see a doctor, and antibiotics are frequently pre-
scribed unnecessarily in these cases.15—17 The main indication
for the use of antibiotics in these children is to treat GAS
pharyngotonsillitis, but this constitutes only a minority of
cases.12,13 In order to reduce bacterial resistance, we simply
need to use antibiotics less.28 In this context, children with
URTIs have been targeted for a reduction in antibiotic use.
In children, viral and bacterial pharyngitis are clinically
indistinguishable,20,21 hence methods have been sought to
identify bacterial cases prior to prescribing antibiotics. Unfor-
tunately, early attempts such as the sore throat score,29 the
World Health Organization (WHO) acute respiratory infections
guidelines, and the WHO clinical decision rule for streptococ-
cal pharyngitis,30,31 have yielded disappointing results. More
recent national campaigns, incorporating evidence-based
guidelines for the management of childhood URTIs with the
education of doctors and the public, have resulted in a dra-
matic reduction in the use of antibiotics.8,9,16,17
At the personal practice level, various methods of rapid
bacterial antigen testing have been tried to facilitate quick
identification of streptococcal pharyngotonsillitis in children
with URTIs. The main disadvantage of these tests has been
their low sensitivity, which renders them not cost-effec-
tive.25—27 The Al-Zahra Microbiology Laboratory employs
the Diaquick Strep. A Test (SAT). This prospective study
was set up to assess the value of this rapid near-patient test
and to validate its use in clinical practice, as well as to
evaluate its effect on antibiotic use among children withURTIs and pharyngotonsillitis attending the outpatient clinics
of one pediatrician.
As expected, the majority of cases included in this study
were young children under 5 years of age and the majority
had viral infections confirmed by a negative culture. Among
bacterial cases, GAS constituted 89% (71/80 positive cul-
tures) — 14% of the whole group (71/505 children). This is
slightly lower than the reported prevalence of 15—36%12,13
and is perhaps due to the fact that cases of acute pharyngo-
tonsillitis without catarrh were not included in the study. In
practice, this group of children constitutes the majority of
cases seen every day by general pediatricians and general
practitioners. Unfortunately, antibiotics are frequently
given, which make children with URTIs the main consumers
of antibiotics.10
Although the positive predictive value was reasonably
high (96%), the SAT negative predictive value was extre-
mely high at over 99% for the whole group as well as for
children under five years of age. Coupled with the very high
sensitivity of 95.8%, the Diaquick Strep. A Test (SAT) was
found to be extremely reliable and useful in clinical practice.
It has two other major advantages: speed and no need for a
follow-up throat swab culture in negative cases. In terms of
antibiotic usage, it reduced the need for antibiotics to only
74 children (15%), whilst a staggering 431 (85%) required no
antibiotic therapy. It is far superior to any other rapid
streptococcal antigen test so far assessed,23—25 and wide
use in clinical practice is highly recommended.
In conclusion the Diaquick Strep. A Test (SAT) is a simple,
quick, and extremely reliable test. It should be incorporated
in the initial assessment of children with fever and URTI/
pharyngotonsillitis. Its use will allow the practicing of a ‘no
initial antibiotics’ policy safely, with a marked reduction in
antibiotic use in these children.
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